IL6 and autoimmune disease: On further adjusted analyses, stratified by the level of expression of specific cytokines in autoimmune diseases, 30-day mortality was reduced in those autoimmune diseases with overexpression of IL-1, IL-6, IL-12, IFN-γ, and TNF-α, as well as in those with reduced expression of IL-4 and IL-10 [66].